Breaking News, Promotions & Moves

LenioBio Names New CTO and CCO

Welcomes Kathrin Knauf as Chief Technology Officer and Malene Linderoth as Chief Commercial Officer.

Author Image

By: Charlie Sternberg

Associate Editor

LenioBio, a life-science company offering an advanced protein expression platform for drug discovery and development, has appointed Kathrin Knauf as Chief Technology Officer and Malene Linderoth as Chief Commercial Officer.   “I am delighted to welcome Kathrin and Malene on board,” said LenioBio CEO, André Goerke. “Their extensive industry experience will be invaluable as we further scale and commercialize our groundbreaking platform technology. They will make pivotal contrib...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters